FCS Support Group Launched September 2016 | A group of concerned patients and care providers for a rare disease have announced the formation of the first-ever organization dedicated to providing education and support for people…
Explore highlights of current education across the Endocrine Society.
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
ENDO Session | No credit available
Faculty: Cecilia C. Low Wang MD; Matthew Cavender, MD, MPH; Jennifer Green, MD; and William T. Cefalu, MD
Hear the latest about underlying mechanisms of cardiovascular disease and the impact of diabetes therapies in patients with diabetes.
Creating Clarity for Very High Triglycerides Care
Online Course | 2.25 AMA PRA Category 1 Credits™
Faculty: Robert Eckel, MD; Michael Miller, MD; Harold Bays, MD; Sergio Fazio, MD, PhD; and Eliot Brinton, MD
Learn about the molecular underpinnings of disease and relationships to endocrinopathies using updated guidelines and case examples.
Trial Updates in Type 2 Diabetes
CEU Satellite Symposium | 1.0 AMA PRA Category 1 Credit™
Carol H. Wysham, MD
Summarize cardiovascular complications and risk factors and integrate updated knowledge into practice, including the latest from the EMPA-REG and LEADER trials.
ENDO Session | No credit available
William F Young, Jr., MD, MSc
Review email consults in a computer-based CPC to learn practical approaches to diagnosing and treating hyperaldosteronism.
Heart Health Digital Toolkit
Patient Resource | No credit available
Reviewer: Robert M. Carey, MD
Check out interactive and downloadable resources and information for patients with questions about cardiovascular health and disease.
Endocrine Facts & Figures: Cardiovascular and Lipids
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on lipid disorders, cardiovascular disease, and endocrine-related risks with current citations and expert insights.
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement Endocrine Reviews | April 5, 2017 William F. Young, Jr., David A. Calhoun, Jacques W.M. Lenders, Michael Stowasser, and Stephen C. Textor
Hypertension affects 28.6% of adults in United States. In most, hypertension is primary (essential or idiopathic), but a subgroup of approximately 15% has secondary hypertension…
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline JCEM | October 6, 2016 Rebecca J. Brown, David Araujo-Vilar, Pik To Cheung, David Dunger, Abhimanyu Garg, Michelle Jack, Lucy Mungai, Elif A. Oral, Nivedita Patni, Kristina I. Rother, Julia von Schnurbein, Ekaterina Sorkina, Takara Stanley, Corinne Vigouroux, Martin Wabitsch, Rachel Williams, and Tohru Yorifuji
Lipodystrophy syndromes are extremely rare disorders of deficient body fat associated with potentially serious metabolic complications, including diabetes, hypertriglyceridemia, and steatohepatitis. Due to their rarity…
Cardiovascular Risk in Women with Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age JCEM | June 14, 2016 Nadine M. P. Daan, Taulant Muka, Maria P. H. Koster, Jaenine E. Roeters van Lennep, Cornelis B. Lambalk, Joop S. E. Laven, Clemens G. K. M. Fauser, Cindy Meun, Yolanda B. de Rijke, Eric Boersma, Oscar H. Franco, Maryam Kavousi, and Bart C. J. M. Fauser
A young age at menopause has been associated with increased cardiovascular disease (CVD) risk. Objective: To compare the cardiovascular risk profile between women with premature ovarian insufficiency…
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment JCEM | March 2, 2016 John W. Funder, Robert M. Carey, Franco Mantero, M. Hassan Murad, Martin Reincke, Hirotaka Shibata, Michael Stowasser, and William F. Young Jr.
For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions…
Evaluation and Treatment of Hypertriglyceridemia JCEM | July 2, 2013 Lars Berglund, John D. Brunzell, Anne C. Goldberg, Ira J. Goldberg, Frank Sacks, Mohammad Hassan Murad, and Anton F. H. Stalenhoef
The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150–999 mg/dl) be diagnosed…
Clinical Endocrinology Update & Endocrine Board Review Dates: September 23–27, 2017 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
Whether you need the latest clinical information or you’re preparing to certify or recertify for the boards, Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR) have you covered.
ENDO Bridge Dates: October 19–22, 2017 Location: Antalya, Turkey Sponsor: Endocrine Society, the European Society of Endocrinology, and The Society of Endocrinology and Metabolism of Turkey
EndoBridge will provide a comprehensive update in the field of endocrinology for the clinical endocrinologist. The official language of the meeting is English, but simultaneous translation will be available in Russian, Arabic, and Turkish
ENDO 2018 Dates: March 17–20, 2018 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
ENDO is the world’s largest event for presenting and obtaining the latest in endocrine science and medicine with an extensive program covering a broad array of topics, various networking opportunities, poster sessions, updates on new products and technologies at the ENDOExpo, and more.